Accelerated Technologies Partners

investment firm

About

Accelerated Technologies Partners (ATP) is an investment partnership that focuses on medical devices.

Details

Industries
Finance,Medical Device,Venture Capital
Operating Status
Active
Investor Type
MVC

Accelerated Technologies Partners (“ATP”) is an investment partnership that focuses on medical devices and actively leverages a structured collaboration between world-leading physicians, experienced operational management and dedicated capital to produce superior returns and substantial clinical value. By aligning the interests and harnessing the collective resources of physicians, management and investors from inception through exit, the ATP strategy supports the acceleration of product development and lowers market and execution risks, enhancing capital efficiency and improving the likelihood of outstanding returns.

Investments

Number of Investments
Number of Lead Investments
6
0
Accelerated Technologies Partners has made 6 investments. Their most recent investment was on Mar 23, 2009, when Claros Diagnostics raised $4M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $4M Genetics
Series A $7.80M Genetics
Jun 30, 2006 Mitralign
Series B $13M Health Care
Jun 8, 2005 Mitralign
Series Unknown $6.70M Health Care
May 10, 2004 Mitralign
Series A $3.50M Health Care

Employee Profiles

Number of Employee Profiles
2
Accelerated Technologies Partners has 2 current employee profiles, including Board member Jack Schuler
Board member
Executive

Exits

Accelerated Technologies Partners has had 3 exits. Accelerated Technologies Partners most notable exits include Mitralign ,   Claros Diagnostics

Date Company Name Exit Type Industry
Mar 11, 2019 Mitralign M&A Health Care Detail
Oct 13, 2011 Claros Diagnostics M&A Genetics Detail
Apr 28, 2005 Impella Cardiosystems M&A Biotechnology Detail